Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
DMXAA
Description:
A small-molecule antitumor agent, 5,6-dimethylxanthenone-4-acetic acid, studied for its effects on immune signaling and tumor treatment.
Related topics:
interferon and immune responses (18%),
Angiogenesis and VEGF in Cancer (17%)
Wikidata ID:
wiki/Q7908310
OpenAlex ID:
keywords/dmxaa
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
2015
·
Leticia Corrales
, Laura Hix Glickman
, et al.
·
Cell Reports
·
1,645
PDF
Disrupting tumour blood vessels
2005
·
Gillian M. Tozer
, Chryso Kanthou
, et al.
·
Nature reviews. Cancer
·
990
Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA
2013
·
Pu Gao
, Manuel Ascano
, et al.
·
Cell
·
628
PDF
Vascular Targeting Agents as Cancer Therapeutics
2004
·
Philip E. Thorpe
·
Clinical Cancer Research
·
612
Xanthone Derivatives: New Insights in Biological Activities
2005
·
M. M.M. Pinto
, M. E. Sousa
, et al.
·
Current Medicinal Chemistry
·
561
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
2013
·
Joseph Conlon
, Dara L Burdette
, et al.
·
The Journal of Immunology
·
476
cGAS-STING pathway in cancer biotherapy
2020
·
Yang Wang
, Jingwen Luo
, et al.
·
Molecular Cancer
·
426
PDF
STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis
2018
·
Yongsheng Yu
, Yu Liu
, et al.
·
Journal of Clinical Investigation
·
410
PDF
Vascular‐targeting therapies for treatment of malignant disease
2004
·
Dietmar W. Siemann
, David J. Chaplin
, et al.
·
Cancer
·
329
PDF
Vascular disrupting agents
2006
·
John W. Lippert
·
Bioorganic & Medicinal Chemistry
·
270
5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
2012
·
Daniel Prantner
, Darren J. Perkins
, et al.
·
Journal of Biological Chemistry
·
231
DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2′3′-cGAMP, Induces M2 Macrophage Repolarization
2014
·
Charlene M. Downey
, Mehrnoosh Aghaei
, et al.
·
PLoS ONE
·
207
PDF
Antivascular therapy of cancer: DMXAA
2003
·
Bruce C Baguley
·
The Lancet Oncology
·
201
STING agonist promotes CAR T cell trafficking and persistence in breast cancer
2020
·
Nuo Xu
, Douglas C. Palmer
, et al.
·
The Journal of Experimental Medicine
·
189
PDF
Anticancer Flavonoids Are Mouse-Selective STING Agonists
2013
·
Sujeong Kim
, Lingyin Li
, et al.
·
ACS Chemical Biology
·
189
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
2016
·
Emily Curran
, Xiufen Chen
, et al.
·
Cell Reports
·
186
PDF
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
2007
·
Zachary J. Roberts
, Nadege Goutagny
, et al.
·
The Journal of Experimental Medicine
·
175
PDF
Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy
2002
·
Dietmar W. Siemann
, Emma Mercer
, et al.
·
International Journal of Cancer
·
174
Activation of Tumor-Associated Macrophages by the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid Induces an Effective CD8+ T-Cell–Mediated Antitumor Immune Response in Murine Models of Lung Cancer and Mesothelioma
2005
·
Arminder S. Jassar
, Eiji Suzuki
, et al.
·
Cancer Research
·
162
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
2020
·
Jingjing Liang
, Huifang Wang
, et al.
·
Science Advances
·
160
PDF
Tumor-Microenvironment-Responsive Nanoconjugate for Synergistic Antivascular Activity and Phototherapy
2018
·
Pingping Liang
, Xiaoyu Huang
, et al.
·
ACS Nano
·
154
STING signaling sensing of DRP1-dependent mtDNA release in kupffer cells contributes to lipopolysaccharide-induced liver injury in mice
2022
·
Qin Zhang
, Jiayi Wei
, et al.
·
Redox Biology
·
152
The first international conference on vascular targeting: meeting overview.
2003
·
Philip E Thorpe
, David J Chaplin
, et al.
·
PubMed
·
151
Effects of 5,6-Dimethylxanthenone-4-Acetic Acid on Human Tumor Microcirculation Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
2002
·
Susan M. Galbraith
, Gordon J.S. Rustin
, et al.
·
Journal of Clinical Oncology
·
147
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent
2003
·
M B Jameson
, P I Thompson
, et al.
·
British Journal of Cancer
·
142
PDF
Show more works
View as search
Works count:
574
Citation count:
18,430
Year
Topic
Type